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REVIEW ARTICLE
Brugada syndrome unmasked by fever: a comprehensive review of literature
Sohaib S. Roomi a, Waqas Ullah a, Hassan Abbasa, Hafez Abdullah b, Usama Talibc
and Vincent Figueredod
aAbington Memorial Hospital, Abington, PA, USA; bUniversity of South Dakota, Sioux Falls, SD, USA; cNorth Shore Medical Center, Salem
Hospital, Salem, MA, USA; dSaint Mary Medical Center, Langhorne, PA, USA
ABSTRACT
Background: The Brugada pattern is identified on the EKG by a coved ST-segment elevation
accompanied by a negative T wave in the early precordial leads in the absence of a cardiac
structural abnormality. Brugada pattern and Brugada syndrome should be differentiated, as
the latter is associated with an increased risk of sudden cardiac death.
Methods: The literature was searched using multiple databases to identify all the articles on
Brugada pattern. Data were screened and analyzed by independent authors.
Results: Sixty articles, comprising 71 patients, were included in the study. The mean age of
patients was 42.6 years, with a higher prevalence of Brugada pattern in men (83%) than
women (17%). The most frequent findings associated with Brugada pattern was fever (83%).
Other less common presentations included cough (21%), sore throat (10%), syncope (18%),
abdominal pain (8%), and chest pain (7%). Comorbidities included pneumonia (30%), upper
respiratory tract infections (14%) and smoking (14%). Among treatment modalities, 39% of
patients had ICD placement performed, 44% received antibiotics, while 14% had supportive
care. Adenosine was given to 3% of patients, while other antiarrhythmics like milrinone,
amiodarone, sotalol, procainamide, flecainide, and nitroglycerin were given to 1% of patients.
Most patients with Brugada syndrome had a satisfactory outcome, with only 4% mortality
rate(WHAT ABOUT THE OTHER 11%?). Out of the 71 patients, 3% had persistent Brugada
patterns, while 86% of patients recovered completely. There was no significant effect of ICD
on mortality or Brugada pattern resolution (p 0.37).
Conclusion: Our study shows that fever is the main reason for unmasking the Brugada
pattern in patients with this channelopathy. ICD placement in such patients is not recom-
mended as it has no mortality benefits.
ARTICLE HISTORY
Received 11 January 2020





branch block; ICD; EKG
1. Introduction
The Brugada pattern was first described in 1992 by
Brugada, characterized by ST-segment elevation
accompanied by a negative T wave in the early pre-
cordial leads without any cardiac structural abnorm-
ality [1]. In 1996, Yan and Antzelevitch proposed that
this ST-segment elevation and right bundle branch
block (RBBB) appearance had a cellular basis for the
development of life-threatening arrhythmias [2]. This
theory further confirmed by Kobayashi et al. and
Miyazaki et al. [3–6] This review aims to summarize
the known literature specifically on the Brugada pat-
tern and also highlights the distinguishing features of
Brugada pattern and Brugada syndrome.
2. Materials and methods
A literature search for relevant articles was performed
using MEDLINE (PubMed, Ovid), Embase, and
Cochrane databases. A total of 60 articles were selected
after initial screening and duplicates removal. The
authors extracted data into an excel sheet identifying
presentation, risk factors, diagnostic modalities, man-
agement, and outcome of patients with Brugada pattern.
3. Results
A total of 71 patients were identified from the
included 60 articles. The mean age was 42.6 years.
Approximately 35% of the patients were 50 years or
older. Of the reported cases, 83% were males, and
17% were females. Overall, the most common pre-
sentation was fever in 83% of patients. Upper respira-
tory symptoms were also reported frequently,
including cough in 21%, sore throat in 10%. Besides
these, syncope was present in 18%, abdominal pain in
8%, chest pain in 7%, arthralgia in 4%, nausea and
vomiting in 4%, and pleuritic chest pain in 3%. The
most common associated comorbidity was pneumo-
nia, present in 30% of patients. An upper respiratory
tract infection was present in 14% of the patients.
Ventricular fibrillation was present in 8% and ven-
tricular tachycardia in 4%. Other comorbidities are
shown in Table 1
CONTACT Sohaib S. Roomi roomigujjar251@gmail.com Abington Memorial Hospital, Abington, PA, USA
JOURNAL OF COMMUNITY HOSPITAL INTERNAL MEDICINE PERSPECTIVES
2020, VOL. 10, NO. 3, 224–228
https://doi.org/10.1080/20009666.2020.1767278
© 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group on behalf of Greater Baltimore Medical Center.
This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/),
which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Thirty nine percent of patients had an ICD placed
for the Brugada pattern. Forty four percent of
patients received antibiotics. As many of the patients
presented with fever or an infection. One patient
underwent defibrillation. Three percent received ade-
nosine, and 1% received milrinone, amiodarone, sota-
lol, procainamide, flecainide or nitroglycerine. This is
shown in Table 2
Most of the patients with the Brugada pattern had
a good outcome. 86% of the patients recovered, while
4% died and 3% had persistent brugada pattern, no
outcome data was available in 7% patients.
The clinical outcomes in these patients were further
assessed based on presentation, comorbidities, and
management. One important characteristic that was
evaluated as if there was any association of ICD place-
ment with better outcomes. A total of 27 patients had an
ICD placed, and out of these patients, 26 (96%) recov-
ered, while one patient had persistent Brugada pattern.
There were no deaths recorded. On the other hand, in
patients that did not receive an ICD, 3 (7%) of the
patients died, 39 (88%) recovered, and 2 (5%) patients
had persistent Brugada pattern. Even though the rate of
death was much higher (6.8% vs. 0%) in patients who
did not receive an ICD, this difference was not statisti-
cally significant (p = 0.372). Figure 1
The outcomes of patients with different presenta-
tions, associations, co-morbidities, and management
options were analyzed, as depicted in Table 3. There
was no statistically significant association, based on
chi-square test, between different outcomes and any
of the above-described feature.
4. Discussion
Our analysis indicates Brugada pattern is
a relatively benign condition mostly unmasked by
fever and has favourable outcomes if the under-
lying conditions are treated. These patients have
channelopathy just like brugada syndrome patients
but they do not have a history of sudden cardiac
death in their family nor have been symptomatic in
life, differentiating them from brugada syndrome.
As per our study, patients with brugada pattern do
not need ICD placement or antiarrhythmic medi-
cations. The brugada pattern resolves with the
management of the underlying condition. Brigada
pattern patients do not have symptoms, so they are
usually unaware of their condition unless diag-
nosed incidentally on EKG.
5. Clinical presentation
Brugada pattern typically is unmasked by fever due to
any cause, mostly in association with a chest infec-
tion. Our study found fever was associated with
Brugada pattern in 83% of presenting patients.
Further, we found the most frequent association was
with pneumonia (30%) and upper respiratory tract
infection (14%). Other findings associated with
Brugada pattern included cough in 21% of the indi-
viduals, sore throat in 10%, syncope in 18%, abdom-
inal pain in 8% and chest pain in 7%.
Brugada pattern typically presents during adult-
hood (42.6% in our study). A study of 384 patients
showed its occurrence in men predominantly (70%)
[7]. Our study showed a higher prevalence in males
(83%) compared to females (17%).
6. Molecular genetics and cellular
mechanisms
Brugada syndrome shows an autosomal dominant
mode of transmission. In 1998, Chen et al. demon-
strated the link of Brugada syndrome to the alpha
subunit of the cardiac sodium channel gene (SCN5A
gene) [8]. The loss of function of this gene can be
caused by a failure of expression of the channel,
Table 1. This table depicts the epidemiology, most common presenting symptoms, and comorbidities
associated with presentation of Brugada pattern.
Epidemiology (n = 71) Percent patients Presenting symptoms (n = 71)
Mean age of presentation 42.6 years Fever 83%
Age 50 and above 35% Cough 21%
Male sex 83% 83% Syncope 18%
Associated Comorbidities Percentage (n = 71) Sore throat 10%
Pneumonia 30% Abdominal pain 8%
Upper respiratory tract infection 14% Chest pain 7%
Smoking 11% Arthralgia 4%
Ventricular fibrillation 8% Vomiting and nausea 4%
Hypertension 7% Pleuritic chest pain 3%
Dyslipidemia 6% Altered mental status 3%
Malaria 4% Seizures,HSM, Diarrhea 1% each
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accelerated inactivation of the pathway, inactivation
of the channel to an intermediate state with a slow
recovery, or a shift in voltage and time-dependent
sodium channel activation, inactivation, or reactiva-
tion [9]. It was observed that the accelerated inactiva-
tion of sodium channels occurred at temperatures
above the physiologic range suggesting the possible
mechanism for Brugada pattern in a febrile state [10].
In 2002, Antzelevitch et al. identified patients of the
Brugada pattern exhibiting fever-induced ventricular
tachycardia (VT) [11].
Various studies conducted to understand the cellu-
lar mechanisms of Brugada pattern suggest
a rebalancing of active currents at the end of phase 1
causing the ST-segment elevation or J wave observed
in the Brugada pattern [12]. The accentuation of the
J wave leads to a saddleback configuration of the
repolarization waves. As the notch becomes more pro-
minent due to the prolongation of an epicardial action
potential, the direction of repolarization across the RV
wall and transmural voltage gradient is reversed. This
leads to a typical dome-like ST segment elevation and
T wave inversion. (Figure 2)
7. Diagnosis
Brugada pattern is characterized by three types of repo-
larization patterns in the right precordial ECG leads.
Out of these three patterns, type 1 pattern is diagnostic
of Brugada, and it consists of a coved ST-segment
elevation of more than 2 mm (0.2 mV) followed by
T wave inversion. Type 2 ECG pattern of Brugada
typically shows a saddleback appearance with an ST-
segment elevation of ≥2 mm, a trough showing ≥1 mm
ST elevation, and a positive or biphasic T wave [8]. In
type 3, there is an ST-segment elevation of <1 mm with
a saddleback or coved appearance. The definitive diag-
nosis in types 2 and 3 is made by the presence of type 1
ST-segment elevation in more than one right precordial
lead (V1 to V3) in the presence or absence of a sodium
channel blocking drug [12]. The three types of Brugada
patterns are illustrated in the figure below. (Figure 2)
It is essential to exclude other factors that could lead to
the these ECG abnormalities, such as atypical RBBB, left
ventricular hypertrophy, acute pericarditis, dissecting
aortic aneurysm, electrolyte abnormalities, ormechanical
compression of the right ventricular outflow tract
(RVOT) [12].
Figure 1. This figure depicts the outcomes in patients who received and those who did not receive an ICD.






Sex 92% vs 90% (males vs females) 0.49
Fever 90% vs 100% (fever vs no fever) 0.51
Syncope 91% vs 92% (syncope vs no syncope) 0.52
Pneumonia/URI 95% vs 88% 0.14
Associations/co-morbidities
Family history of Brugada 71% vs 94% (family history vs no family history) 0.13
Family history of SCD 80% vs 92% (family history vs no family history) 0.17
Hypertension 100% vs 91% (Hypertension vs no Hypertension) 0.82
Smoking 88% vs 92% (smoking vs no smoking) 0.39
Management
ICD 96% vs 89% 0.37
Antibiotics 94% vs 0.9% 0.22
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8. Management
Over the past few years, a considerable amount of pro-
gress has been observed in the diagnosis and character-
ization of Brugada pattern and syndrome. However, the
same cannot be said about its management. For Brugada
syndrome, an ICD has proved to be the only definitive
treatment [13]. However, its use is riddled with limita-
tions. It is not a feasible treatment option in infants and
young children, and in some parts of the world, its
implantation is extremely expensive. Patients with
Brugada pattern, however, require supportive care and
treatment of febrile illness. There was no significant ben-
efit of ICD or pacemaker noted in our review on the
Brugada pattern
Other options in Brugada syndrome are pharmacolo-
gical therapy, including quinidine to restore the epicar-
dial action potential dome, leading to normalization of
the ST segment and preventing phase 2 reentry and
development of VT [14]. However, its use in the preven-
tion of sudden death has not been established. Other
antiarrhythmic drugs such as amiodarone and beta-
blockers have been observed to be ineffective, whereas
class IA antiarrhythmic such as procainamide and class
IC antiarrhythmics such as flecainide and propafenone
are contraindicated [15]. Our study, however, focused on
the management of the Brugada pattern only and
revealed that 39% of patients had ICD placement
performed for Brugada pattern due to other compelling
indications (family history of sudden deaths, low ejection
fraction). Most patients (44%) were started on antibiotics
for the treatment of underlying febrile illness while sup-
portive care was given to 14% of patients. Only a few
patients had antiarrhythmic therapies, adenosine (3%)
and milrinone, amiodarone, sotalol, procainamide, fle-
cainide, and nitroglycerin were given to 1% of patients.
9. Outcome
According to our study, most patients with the Brugada
pattern had a satisfactory outcome, with amortality rate
of only 4%. Out of the 71 patients, 3% had persistent
Brugada patterns, while 86% of patients recovered com-
pletely. When the recovery pattern of the different
treatment modalities was assessed, 96.3% of patients
with ICD placement had a complete recovery, while in
patients who underwent conservative treatment, 88.6%
recovered completely, 4.5% had persistent Brugada pat-
tern, and 6.8% (n = 3) patients died.
10. Conclusions
Brugada syndrome is associated with a high incidence of
sudden deaths in adults with structurally healthy hearts
and should be managed with ICD, pacemaker, or
Figure 2. EKG of a patient with Brugada syndrome with three characteristic patterns. The left panel shows a type 1 ECG,
whereas the middle and right panels show type 2 and 3 ECGs.
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antiarrhythmic medications. Brugada pattern, on the
other hand, is a benign condition usually unmasked by
fever and can be reversed by alleviating the cause of
illness. ICD has no mortality benefit in the Brugada
pattern.
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